According to Zhitong Finance App, China Resources Pharmaceutical (03320) announced that China Resources Liberal Arts Biotech obtained total operating revenue of RMB 847 million (same unit) for the nine months ended September 30, 2026, a year-on-year decrease of 42.54%; net profit of 605.883 million yuan, a year-on-year decrease of 82.34%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.